gsk3862995b
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 27, 2023 (NCT06154837)
Timeline
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07201051 | Phase 2 | Sep 26, 2025 | GlaxoSmithKline |
| NCT06979518 | Phase 1 | May 20, 2025 | GlaxoSmithKline |
| NCT06154837 | Phase 1 | Nov 27, 2023 | GlaxoSmithKline |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| GlaxoSmithKline | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1